Transcriptomic dataset of
DEGs
Drug development
Mycolicibacterium smegmatis
RNA sequencing
Transcriptome
Tuberculosis
imidazo[1,2-b][1,2,4,5]tetrazines
Journal
Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
12
04
2020
revised:
19
05
2020
accepted:
22
05
2020
entrez:
23
6
2020
pubmed:
23
6
2020
medline:
23
6
2020
Statut:
epublish
Résumé
Deciphering the mechanism of action of novel anti-tuberculosis compounds is a key step in the drug development process. We have previously described a number of imidazo[1,2-
Identifiants
pubmed: 32566706
doi: 10.1016/j.dib.2020.105805
pii: S2352-3409(20)30699-5
pii: 105805
pmc: PMC7298395
doi:
Types de publication
Journal Article
Langues
eng
Pagination
105805Informations de copyright
© 2020 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships which have, or could be perceived to have, influenced the work reported in this article.
Références
Eur J Med Chem. 2019 Sep 15;178:39-47
pubmed: 31176094
Pathogens. 2020 Feb 18;9(2):
pubmed: 32085490
Pathogens. 2020 Feb 28;9(3):
pubmed: 32121069
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Methods Mol Biol. 2009;465:13-21
pubmed: 20560069
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308